Total Payments
$3,050
2024 Payments
$652.08
Companies
10
Transactions
48
Medicare Patients
129
Medicare Billing
$18,276
Payment Breakdown by Category
Food & Beverage$2,878 (94.4%)
Education$171.24 (5.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,878 | 44 | 94.4% |
| Education | $171.24 | 4 | 5.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $695.62 | 12 | $0 (2024) |
| ABBVIE INC. | $658.07 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $499.40 | 7 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $327.85 | 3 | $0 (2022) |
| Alkermes, Inc. | $310.73 | 5 | $0 (2023) |
| ITI, Inc. | $244.67 | 3 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $120.65 | 1 | $0 (2023) |
| Axsome Therapeutics, Inc. | $99.50 | 1 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $78.33 | 5 | $0 (2024) |
| OWP Pharmaceuticals, Inc. | $14.78 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $652.08 | 14 | Teva Pharmaceuticals USA, Inc. ($359.58) |
| 2023 | $934.63 | 16 | Teva Pharmaceuticals USA, Inc. ($336.04) |
| 2022 | $717.79 | 9 | Janssen Pharmaceuticals, Inc ($248.19) |
| 2021 | $745.10 | 9 | Neurocrine Biosciences, Inc. ($234.74) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $118.54 | General |
| Category: Neuroscience | ||||||
| 10/21/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: Neuroscience | ||||||
| 08/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Neuroscience | ||||||
| 08/07/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $124.89 | General |
| Category: Neurology | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Oxtellar XR (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: OXCARBAZEPINE | ||||||
| 07/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $120.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $97.50 | General |
| Category: Neurology | ||||||
| 05/21/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.47 | General |
| Category: Central Nervous System | ||||||
| 04/30/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $9.85 | General |
| Category: Neuroscience | ||||||
| 04/23/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $105.50 | General |
| 04/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Neurology | ||||||
| 04/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: Central Nervous System | ||||||
| 03/19/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Neurology | ||||||
| 01/31/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: Central Nervous System | ||||||
| 10/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.12 | General |
| Category: Central Nervous System | ||||||
| 09/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $60.37 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: CNS | ||||||
| 09/12/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: PSYCHOLOGY | ||||||
| 08/29/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $95.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/29/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: PSYCHOLOGY | ||||||
| 08/29/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: Central Nervous System | ||||||
| 08/23/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $199.27 | General |
| Category: Neurology | ||||||
| 08/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $48.84 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $122.59 | General |
| Category: Central Nervous System | ||||||
| 06/26/2023 | ABBVIE INC. | VRAYLAR (Drug) | Education | In-kind items and services | $8.45 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 38 | 120 | $26,362 | $7,462 |
| 2022 | 3 | 41 | 90 | $17,639 | $4,998 |
| 2021 | 3 | 39 | 83 | $14,303 | $4,776 |
| 2020 | 1 | 11 | 11 | $3,329 | $1,041 |
Total Patients
129
Total Services
304
Medicare Billing
$18,276
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 107 | $21,339 | $6,242 | 29.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 13 | 13 | $5,023 | $1,220 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 58 | $11,022 | $3,161 | 28.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 11 | 11 | $3,759 | $1,035 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 21 | $2,858 | $801.94 | 28.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 28 | $5,045 | $1,816 | 36.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 43 | $5,359 | $1,653 | 30.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 12 | 12 | $3,898 | $1,307 | 33.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 11 | 11 | $3,329 | $1,041 | 31.3% |
About Matthew Hettenbach, PMHNP
Matthew Hettenbach, PMHNP is a Psychiatric/Mental Health healthcare provider based in Racine, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2020. The National Provider Identifier (NPI) number assigned to this provider is 1003430729.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Matthew Hettenbach, PMHNP has received a total of $3,050 in payments from pharmaceutical and medical device companies, with $652.08 received in 2024. These payments were reported across 48 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,878).
As a Medicare-enrolled provider, Hettenbach has provided services to 129 Medicare beneficiaries, totaling 304 services with total Medicare billing of $18,276. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Location Racine, WI
- Active Since 05/29/2020
- Last Updated 05/29/2020
- Taxonomy Code 363LP0808X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003430729
Products in Payments
- VRAYLAR (Drug) $658.07
- UZEDY (Drug) $438.75
- INGREZZA (Drug) $327.85
- SPRAVATO (Drug) $254.16
- INVEGA SUSTENNA (Drug) $245.24
- CAPLYTA (Drug) $244.67
- LYBALVI (Drug) $186.52
- Austedo XR (Drug) $151.37
- ARISTADA (Drug) $124.21
- QUVIVIQ (Drug) $120.65
- Auvelity (Drug) $99.50
- QELBREE (Drug) $65.15
- SUBVENITE (Drug) $14.78
- Oxtellar XR (Drug) $13.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Racine
Carol Baird, Apnp, APNP
Psychiatric/Mental Health
Psychiatric/Mental Health
Julie Nigh
Psychiatric/Mental Health
Psychiatric/Mental Health
Mrs. Nancy Maczka, Adult Pmhnp, ADULT PMHNP
Psychiatric/Mental Health
Psychiatric/Mental Health
Dej Thor, Pmhnp, PMHNP
Psychiatric/Mental Health
Psychiatric/Mental Health